The molecular pathophysiology of vascular anomalies: Genomic research

 

 Permissions and Reprints

Vascular anomalies are congenital localized abnormalities that result from improper development and maintenance of the vasculature. The lesions of vascular anomalies vary in location, type, and clinical severity of the phenotype, and the current treatment options are often unsatisfactory. Most vascular anomalies are sporadic, but patterns of inheritance have been noted in some cases, making genetic analysis relevant. Developments in the field of genomics, including next-generation sequencing, have provided novel insights into the genetic and molecular pathophysiological mechanisms underlying vascular anomalies. These insights may pave the way for new approaches to molecular diagnosis and potential disease-specific therapies. This article provides an introduction to genetic testing for vascular anomalies and presents a brief summary of the etiology and genetics of vascular anomalies.

Publication History

Received: 06 April 2020

Accepted: 30 April 2020

Article published online:
22 March 2022

© 2020. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• REFERENCES

• 1 Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412-22
  CrossrefPubMedGoogle Scholar
• 2 Mulliken JB, Burrows PE, Fishman DJ. Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd ed.. New York: Oxford University Press; 2013
  Google Scholar
• 3 Greene AK, Goss JA. Vascular anomalies: from a clinicohistologic to a genetic framework. Plast Reconstr Surg 2018; 141: 709e-717e
  CrossrefPubMedGoogle Scholar
• 4 Lee JW, Chung HY. Vascular anomalies of the head and neck: current overview. Arch Craniofac Surg 2018; 19: 243-7
  CrossrefPubMedGoogle Scholar
• 5 Queisser A, Boon LM, Vikkula M. Etiology and genetics of congenital vascular lesions. Otolaryngol Clin North Am 2018; 51: 41-53
  CrossrefPubMedGoogle Scholar
• 6 Collins FS, Morgan M, Patrinos A. The Human Genome Project: lessons from large-scale biology. Science 2003; 300: 286-90
  CrossrefPubMedGoogle Scholar
• 7 Sohn J. Next generation sequencing and anti-cancer therapy. J Korean Med Assoc 2019; 62: 119-29
  CrossrefGoogle Scholar
• 8 Koboldt DC, Steinberg KM, Larson DE. et al. The next-generation sequencing revolution and its impact on genomics. Cell 2013; 155: 27-38
  CrossrefPubMedGoogle Scholar
• 9 Wetzel-Strong SE, Detter MR, Marchuk DA. The pathobiology of vascular malformations: insights from human and model organism genetics. J Pathol 2017; 241: 281-93
  CrossrefPubMedGoogle Scholar
• 10 Adams DM. Practical genetic and biologic therapeutic considerations in vascular anomalies. Tech Vasc Interv Radiol 2019; 22: 100629
  CrossrefPubMedGoogle Scholar
• 11 International Society for the Study of Vascular Anomalies (ISSVA). ISSVA classification of vascular anomalies [Internet]. Milwaukee, WI: ISSVA. c2018 [cited 2020 May 11]. Available from: issva.org/classification
  Google Scholar
• 12 North PE, Waner M, Brodsky MC. Are infantile hemangiomas of placental origin?. Ophthalmology 2002; 109: 633-4
  CrossrefPubMedGoogle Scholar
• 13 Khan ZA, Boscolo E, Picard A. et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. Version 2. J Clin Invest 2008; 118: 2592-9
  PubMedGoogle Scholar
• 14 Jinnin M, Medici D, Park L. et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 2008; 14: 1236-46
  CrossrefPubMedGoogle Scholar
• 15 Uebelhoer M, Boon LM, Vikkula M. Vascular anomalies: from genetics toward models for therapeutic trials. Cold Spring Harb Perspect Med 2012; 2: a009688
  PubMedGoogle Scholar
• 16 Nasseri E, Piram M, McCuaig CC. et al. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol 2014; 70: 75-9
  CrossrefPubMedGoogle Scholar
• 17 Ayturk UM, Couto JA, Hann S. et al. Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma. Am J Hum Genet 2016; 98: 789-95
  CrossrefPubMedGoogle Scholar
• 18 Groesser L, Peterhof E, Evert M. et al. BRAF and RAS mutations in sporadic and secondary pyogenic granuloma. J Invest Dermatol 2016; 136: 481-6
  CrossrefPubMedGoogle Scholar
• 19 Lim YH, Bacchiocchi A, Qiu J. et al. GNA14 somatic mutation causes congenital and sporadic vascular tumors by MAPK activation. Am J Hum Genet 2016; 99: 443-50
  CrossrefPubMedGoogle Scholar
• 20 Ji Y, Chen S, Yang K. et al. Kaposiform hemangioendothelioma: current knowledge and future perspectives. Orphanet J Rare Dis 2020; 15: 39
  CrossrefPubMedGoogle Scholar
• 21 Lee JW, Chung HY. Capillary malformations (Portwine Stains) of the head and neck: natural history, investigations, laser, and surgical management. Otolaryngol Clin North Am 2018; 51: 197-211
  CrossrefPubMedGoogle Scholar
• 22 Shirley MD, Tang H, Gallione CJ. et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 2013; 368: 1971-9
  CrossrefPubMedGoogle Scholar
• 23 Couto JA, Ayturk UM, Konczyk DJ. et al. A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth. Angiogenesis 2017; 20: 303-6
  CrossrefPubMedGoogle Scholar
• 24 Couto JA, Huang L, Vivero MP. et al. Endothelial cells from capillary malformations are enriched for somatic GNAQ mutations. Plast Reconstr Surg 2016; 137: 77e-82e
  CrossrefPubMedGoogle Scholar
• 25 Eerola I, Boon LM, Mulliken JB. et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003; 73: 1240-9
  CrossrefPubMedGoogle Scholar
• 26 Amyere M, Revencu N, Helaers R. et al. Germline loss-of-function mutations in EPHB4 cause a second form of Capillary Malformation-Arteriovenous Malformation (CMAVM2) deregulating RAS-MAPK signaling. Circulation 2017; 136: 1037-48
  CrossrefPubMedGoogle Scholar
• 27 Cho BC, Kim JB, Lee JW. et al. Cervicofacial lymphatic malformations: a retrospective review of 40 cases. Arch Plast Surg 2016; 43: 10-8
  Article in Thieme ConnectPubMedGoogle Scholar
• 28 Boscolo E, Coma S, Luks VL. et al. AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation. Angiogenesis 2015; 18: 151-62
  CrossrefPubMedGoogle Scholar
• 29 Osborn AJ, Dickie P, Neilson DE. et al. Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations. Hum Mol Genet 2015; 24: 926-38
  CrossrefPubMedGoogle Scholar
• 30 Park H, Kim JS, Park H. et al. Venous malformations of the head and neck: a retrospective review of 82 cases. Arch Plast Surg 2019; 46: 23-33
  Article in Thieme ConnectPubMedGoogle Scholar
• 31 Uebelhoer M, Natynki M, Kangas J. et al. Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB. Hum Mol Genet 2013; 22: 3438-48
  CrossrefPubMedGoogle Scholar
• 32 Couto JA, Vivero MP, Kozakewich HP. et al. A somatic MAP3K3 mutation is associated with verrucous venous malformation. Am J Hum Genet 2015; 96: 480-6
  CrossrefPubMedGoogle Scholar
• 33 Brouillard P, Boon LM, Mulliken JB. et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (“glomangiomas”). Am J Hum Genet 2002; 70: 866-74
  CrossrefPubMedGoogle Scholar
• 34 Soblet J, Kangas J, Natynki M. et al. Blue Rubber Bleb Nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations. J Invest Dermatol 2017; 137: 207-16
  CrossrefPubMedGoogle Scholar
• 35 Cavalcanti DD, Kalani MY, Martirosyan NL. et al. Cerebral cavernous malformations: from genes to proteins to disease. J Neurosurg 2012; 116: 122-32
  Google Scholar
• 36 Kim JB, Lee JW, Choi KY. et al. Clinical characteristics of arteriovenous malformations of the head and neck. Dermatol Surg 2017; 43: 526-33
  CrossrefPubMedGoogle Scholar
• 37 Couto JA, Huang AY, Konczyk DJ. et al. Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation. Am J Hum Genet 2017; 100: 546-54
  CrossrefPubMedGoogle Scholar
• 38 Bayrak-Toydemir P, McDonald J, Akarsu N. et al. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 2006; 140: 2155-62
  PubMedGoogle Scholar
• 39 Cole SG, Begbie ME, Wallace GM. et al. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 2005; 42: 577-82
  CrossrefPubMedGoogle Scholar
• 40 Sung HM, Chung HY, Lee SJ. et al. Clinical experience of the Klippel-Trenaunay syndrome. Arch Plast Surg 2015; 42: 552-8
  Article in Thieme ConnectPubMedGoogle Scholar
• 41 Jacob AG, Driscoll DJ, Shaughnessy WJ. et al. Klippel-Trenaunay syndrome: spectrum and management. Mayo Clin Proc 1998; 73: 28-36
  CrossrefPubMedGoogle Scholar
• 42 Luks VL, Kamitaki N, Vivero MP. et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 2015; 166: 1048-54
  CrossrefPubMedGoogle Scholar
• 43 Mirzaa GM, Riviere JB, Dobyns WB. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet 2013; 163C: 122-30
  PubMedGoogle Scholar
• 44 Kurek KC, Luks VL, Ayturk UM. et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 2012; 90: 1108-15
  CrossrefPubMedGoogle Scholar
• 45 Lindhurst MJ, Sapp JC, Teer JK. et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011; 365: 611-9
  CrossrefPubMedGoogle Scholar
• 46 Amary MF, Damato S, Halai D. et al. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 2011; 43: 1262-5
  CrossrefPubMedGoogle Scholar